Authors: Thomas, RR Dahut, W Harold, N Grem, JL Monahan, BP Liang, M Band, RA Cottrell, J Llorens, V Smith, JA Corse, W Arbuck, SG Wright, J Chen, AP Hamilton, JM Allegra, CJ Takimoto, CH

Citation: Rr. Thomas et al., A phase I and pharmacologic study of 9-aminocamptothecin administered as a120-h infusion weekly to adult cancer patients, CANC CHEMOT, 48(3), 2001, pp. 215-222

Authors: Breathnach, OS Georgiadis, MS Schuler, BS Pizzella, P Llorens, V Kasturi, V Steinberg, SM O'Neil, K Takimoto, CH Johnson, BE

Citation: Os. Breathnach et al., Phase II trial of paclitaxel by 96-hour continuous infusion in combinationwith cisplatin for patients with advanced non-small cell lung cancer, CLIN CANC R, 6(7), 2000, pp. 2670-2676

Authors: Takimoto, CH Morrison, G Harold, N Quinn, M Monahan, BP Band, RA Cottrell, J Guemei, A Llorens, V Hehman, H Ismail, AS Flemming, D Gosky, DM Hirota, H Berger, SJ Berger, NA Chen, AP Shapiro, JD Arbuck, SG Wright, J Hamilton, JM Allegra, CJ Grem, JL

Citation: Ch. Takimoto et al., Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients, J CL ONCOL, 18(3), 2000, pp. 659-667